GOA Therapeutics Names Former Novartis Executive Chief Commercial Officer
GOA Therapeutics announced that Scott Howell, formerly Novartis’ U.S. Chief Strategy Officer, has joined as Chief Commercial Officer.
GOA Therapeutics announced that Scott Howell, formerly Novartis’ U.S. Chief Strategy Officer, has joined as Chief Commercial Officer.